Summarized by Masters of Longevity from FDA - Drugs.
FDA updated labels for multiple menopausal hormone therapies.
Key Takeaways
- FDA updated labels to reflect newly identified safety issues.
- Labels now include revised warnings about potential long-term risks.
- Prescribers are advised to review updated labeling before continuing therapy.
